Skip Ribbon Commands
Skip to main content
 

 Closed Trials

 
  
  
Study Description
  
Leukemia
  
To study the presence of human marginal zone (MZ) B cell markers in chronic lymphocytic leukemias carrying unmutated variable heavy chain antibody genes.
6/22/2011
Breast
  
NSABP B44 BETH - A Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients with HER2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Plus Trastuzumab Plus Bevacizumab CIRG (TRIO) 011/NSABP B44-1/B020906.
9/22/2010